Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the detailed record of transactions filed by Aurentz Vincent, Vice-Président Exécutif. Insider active across 2 companies, notably Arena Pharmaceuticals INC. Cumulatively, 3 disclosures have been logged. Activity tracked since 3 January 2022. The latest transaction was disclosed on 21 February 2026 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Vincent Aurentz is the Executive Vice President and Chief Business Officer at Arena Pharmaceuticals Inc. He is responsible for business strategy and development. Arena Pharmaceuticals Inc. is a biopharmaceutical company dedicated to innovation in treatments.